|
|
Transcripts that showed significantly increased expression in mdt-15(tm2182) comparing to in N2 at L4 larva stage. |
p-value < 0.05, fold change > 2. |
WBPaper00065288:mdt-15(tm2182)_upregulated
|
|
UVC-EtBr-exposed(exposed to 7.5 J/m2 UVC radiation 3 times, 24 h apart (48 h total) and exposed to EtBr (5ug/mL in agar).) vs UVC-exposed(exposed to 7.5 J/m2 UVC radiation 3 times, 24 h apart (48 h total).) at just prior to the second UVC dose (24h). |
Genes differentially expressed under EtBr treatment and UVC exposure vs under UVC exposure but without EtBr treatment at the -25h timepoint (just prior to the second UVC dose (24h)). |
Transcripts were defined as fold-change >1.2, p < 0.05 based on Rosetta Resolver analysis for all pairwise treatment comparisons. The fold-change refers to the second intensity over the first. |
WBPaper00041939:UVC-EtBr-exposed_vs_UVC-exposed_24h
|
|
|
Genes with no change in hcf-1(-), no change in sir-2.1(O/E) and upregulated in daf-2(-). |
To identify the genes that show consistent and significant expression changes across the independent biological replicates of hcf-1(-) or sir-2.1(O/E), authors used Significance Analysis of Microarrays (SAM) with a stringent criteria of expected false discovery rate (FDR) set at 0%. |
WBPaper00040184:hcf-1nc_sir-2.1nc_daf-2up
|
|
|
Transcripts that showed significantly increased expression in lsl-1(ljm1) comparing to in N2 animals. |
DESeq2, q-value <= 0.01 and fold change >= 2. |
WBPaper00062587:lsl-1(ljm1)_upregulated
|
|
|
Transcripts that showed significantly increased expression in lsl-1(tm4769) comparing to in N2 animals. |
DESeq2, q-value <= 0.01 and fold change >= 2. |
WBPaper00062587:lsl-1(tm4769)_upregulated
|
|
|
Transcripts that showed significantly decreased expression in ash-2(RNAi) comparing to in wild type animals injected with vector. |
Differential mRNA expression using DESeq2. mRNAs with a FDR < 0.05 and fold change > 2 considered differentially expressed. |
WBPaper00066232:ash-2(RNAi)_downregulated_WT
|
|
|
Transcripts that showed significantly increased expression in scc-1(ubs19);coh-1(ubs26) comparing to in control animals. |
DESeq2 v.1.34, fold change > 2, FDR < 0.05. |
WBPaper00067078:scc-1(ubs19);coh-1(ubs26)_upregulated
|
|
|
Genes up regulated in the absence of TDP-1, when the threshold was set at a fold change (FC) of 1.2. |
The management and statistical analysis of the microarray data were performed using the Partek Genomic Suite (Partek, Missouri) and Spotfire DecisionSite software (TIBCO, California). |
WBPaper00040603:tdp-1(lf)_up_vs_N2_FC_1.2
|
|
Bacteria infection: Serratia marcescens |
Caenorhabditis elegans Genes with expression levels changed significantly after treatment of Serratia marcescens. |
Differential expression were calculated by empirical eBayes method using eBayes function. P_value <= 0.01 and log2 fold change > 1 were used to call differentially expressed genes in all datasets. |
WBPaper00041606:CE_S.marcescens_regulated
|
|
|
Transcripts that showed significantly increased expression in RB1035[flcn-1(ok975)] comparing to in N2 at young adult stage. |
Agilent microarray raw data were processed and quantile normalized with the marray package from the Bioconductor project. Fold change statistics and Students t-test were used to create lists of candidates for differential gene expression. |
WBPaper00042236:flcn-1(ok975)_upregulated
|
|
|
Transcripts that showed significantly increased expression in scc-1(ubs19) comparing to in control animals. |
DESeq2 v.1.34, fold change > 2, FDR < 0.05. |
WBPaper00067078:scc-1(ubs19)_upregulated
|
|
|
Transcripts that showed significantly increased expression in kle-2(ubs14) comparing to in control animals. |
DESeq2 v.1.34, fold change > 2, FDR < 0.05. |
WBPaper00067078:kle-2(ubs14)_upregulated
|
